209335-49-9CC(C)[C@H](NC(=O)C(NC(=O)C(N)c1ccc(O)cc1)c1cc(O)cc(O)c1)C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)c1cc(O)cc(O)c1)C(C)C)c1cc(O)cc(O)c1)c1ccc(O)cc1)c1cc(O)cc(O)c1)c1ccc(O)cc1)c1cc(O)cc(O)c1MMEABZSPJUJUFX-PYQUZDJWSA-N209335-49-9VerwendenFeglymycin is an amphoteric, 13-member, linear peptide featuring 3,5-dihydroxyphenylalanine and a terminal dicarboxylate amino acid, isolated from a Streptomyces in 1999. Feglymycin is a potent antiviral agent with antibacterial activity, including against MRSA. Feglymycin specifically inhibits the enzymes MurA and MurC and inhibits cell-to-cell transfer between HIV-infected T cells, uninfected CD4+ T cells, and the DC-SIGN-mediated viral transfer to CD4+ T cells.
Wird geladen…
Wird geladen…
Keine Reaktionsaufzeichnungen unter den aktuellen Filterkriterien.
Wird geladen…